Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 308190, 10 pages
http://dx.doi.org/10.1155/2015/308190
Research Article

Low Magnesium Levels and FGF-23 Dysregulation Predict Mitral Valve Calcification as well as Intima Media Thickness in Predialysis Diabetic Patients

1Nephrology, Hospital de Faro, Rua Leão Penedo, 8000-386 Faro, Portugal
2Fresenius Medical Care Deutschland GmbH, 61352 Bad Homburg, Germany
3Pathology Clinic, Hospital de Faro, 8000-386 Faro, Portugal
4Cardiology, Hospital de Faro, 8000-386 Faro, Portugal
5Pharmacology, Gnostic Laboratory, 8000-386 Faro, Portugal

Received 31 August 2014; Accepted 15 October 2014

Academic Editor: Ilias Migdalis

Copyright © 2015 Ana Paula Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Mario Cozzolino, and Marzia Pasquali, “Where is the link between mineral bone markers and cardiovascular disease in CKD?,” Clinical Kidney Journal, pp. sfv104, 2015. View at Publisher · View at Google Scholar
  • Kedan Cai, Qun Luo, Zhiwei Dai, Beixia Zhu, Jinping Fei, Congping Xue, and Dan Wu, “Hypomagnesemia Is Associated with Increased Mortality among Peritoneal Dialysis Patients,” Plos One, vol. 11, no. 3, 2016. View at Publisher · View at Google Scholar
  • Gromova, Torshin, Nazarenko, and Kalacheva, “Deficiency of magnesium and pyridoxine as a risk factor for coronary heart disease,” Kardiologiya, vol. 56, no. 10, pp. 55–62, 2016. View at Publisher · View at Google Scholar
  • Mariano Rodríguez Portillo, and María E. Rodríguez-Ortiz, “Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies,” Reviews in Endocrine and Metabolic Disorders, vol. 18, no. 1, pp. 79–95, 2017. View at Publisher · View at Google Scholar
  • Rebecca B. Costello, and Forrest Nielsen, “Interpreting magnesium status to enhance clinical care,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 20, no. 6, pp. 504–511, 2017. View at Publisher · View at Google Scholar
  • Lucie Hénaut, and Ziad A. Massy, “Magnesium as a Calcification Inhibitor,” Advances in Chronic Kidney Disease, vol. 25, no. 3, pp. 281–290, 2018. View at Publisher · View at Google Scholar
  • Kamonwan Tangvoraphonkchai, and Andrew Davenport, “Magnesium and Cardiovascular Disease,” Advances in Chronic Kidney Disease, vol. 25, no. 3, pp. 251–260, 2018. View at Publisher · View at Google Scholar
  • Emel S. Gökmen, Bennur Esen, Seher Kara, Müslüm Erdem, Dede Şit, Saadet P. Güzel, Ahmet E. Atay, Hasan Kayabaşi, and Elif Yorulmaz, “The association of FGF-23, IL-1 and KIM-1 with progression and mortality rates of chronic kidney disease,” Turkish Nephrology, Dialysis and Transplantation Journal, vol. 27, no. 3, pp. 229–235, 2018. View at Publisher · View at Google Scholar
  • Chia-Liang Wang, Kuan-Pin Lin, Guoo-Shyng W. Hsu, Kai-Li Liu, and Chih-Hung Guo, “Altered Mineral Metabolism and Disequilibrium Between Calcification Promoters and Inhibitors in Chronic Hemodialysis Patients,” Biological Trace Element Research, 2019. View at Publisher · View at Google Scholar